SCHEMBL16341534

SCHEMBL16341534

c1cncc(-c2cccc(-n3ccc4c5c(ccc43)[nH]c3ccccc35)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 1/20 0.44
▸ CCND1 P24385 1/20 0.44
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ CYP2A6 P11509 1/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TDO2 P48775 1/20 0.37
▸ PIM1 P11309 3/20 0.37
▸ PDE10A Q9Y233 1/20 0.36
▸ PIM3 Q86V86 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20427219 0.77 CYP2A6 (0.42) CYP11B2MAPTCYP2A6NPC1HTT
SCHEMBL20427136 0.77 CYP2A6 (0.35) CYP11B2MAPTCYP2A6MEN1NPC1
SCHEMBL20427198 0.76 CDK4 (0.39) CDK4CCND1CYP11B1MAPTKDM4E
SCHEMBL16357383 0.75 MAPT (0.38) CYP11B2MAPTCYP2A6NPC1ALDH1A1
SCHEMBL20427133 0.74 MAPT (0.39) CYP11B1CYP11B2MAPTCYP2A6NPC1
SCHEMBL20426870 0.71 CYP2A6 (0.38) CYP11B2MAPTCYP2A6PIM1PDE10A
SCHEMBL20426224 0.71 MAPT (0.37) CYP11B2MAPTCYP2A6KDM4EMEN1
SCHEMBL16321708 0.70 L3MBTL1 (0.44) MAPTCYP2A6KDM4EMEN1NPC1
SCHEMBL15857151 0.69 MAPT (0.36) CYP11B2MAPTCYP2A6MEN1NPC1
SCHEMBL16357517 0.69 MAPT (0.39) CYP11B2MAPTCYP2A6NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU CDK4 2049/4885CCND1 1823/4885CYP11B1 949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback